The Highlights

Gate2Brain part of the CDTI’s NEOTEC program

,

Gate2Brain part of the CDTI’s NEOTEC program

,

News & Media

Gate2Brain arrives at Alhambra Venture with technology that crosses the brain barrier

,
Ninety-eight percent of drugs designed to treat neurological diseases never reach the brain. The blood-brain…

UCAM LifeTech Summit Awards Gate2Brain for Its Impact

, ,
The third edition of the LifeTech Summit, organized by UCAM HiTech, the UCAM innovation and business…

Spain & India, working in the clinical development for a novel therapy against pediatric brain tumors

Gate2Brain Gate2Brain has developed a disruptive technology aimed at enhancing drug delivery to…

Validation of Gate2Brain Technology in the Transport of Antibodies to the Brain Opens the Avenue of the Next Generation of CNS Therapeutics with Improved Delivery to the Brain

,
Image: Marina Plaza Press release New research highlights how advanced peptide shuttles—the…

Clàudia Resa, G2B’s Doctoral Industrial PhD student : “I am proud have developed a new drug delivery system against childhood brain cancer”

, ,
Research in pediatric oncology: Clàudia Resa is the industrial doctoral student in the project between…

Imitating nature to improve health

, ,
Regenerating skin or delivering medication to specific areas of our body is now possible thanks to the…

Science or science fiction? Research that reads like something out of a book

,
Long before the first robot hoover existed, the laws that would shape its relationship with humans had…

Gate2brain Achieves Emerging Company Certification from Enisa

,
Gate2brain S.L. has proudly received the Emerging Company Certification issued by the Ministry of Industry…

Bioengineering the Future of Drug Delivery workshop – Porto

,
Our CEO, Meritxell Teixido, and Chemist Research Scientist Marina Plaza Garrido recently participated…

New Trends in Peptides for Brain Delivery

Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | Boston

,
📅 April 1-3, 2025 📍 Boston, USA We’re excited to share that Gate2Brain will be participating…

A Site-Specific MiniAp4−Trastuzumab Conjugate Prevents Brain Metastasis

Year: 2025 Authors: Mariam Masmudi-Martín, María Perea, Meritxell Teixidó, Manuel Valiente, Ernest…

Internations Women’s Day – TV3 Interview

,
Breaking Barriers: Women's Entrepreneurship in Focus On International Women's Day, we reflect on the…

4YFN 2025

This week, the Gate2Brain team had the pleasure of attending 4YFN, the startup event at the heart of…

Keystone Symposia on Drug Delivery to the Brain: Emerging Modalities

,
Breaking Barriers and Sharing Innovation with Leaders in Brain Drug Delivery At Gate2Brain, we are…
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social